These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 7923112

  • 1. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.
    Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM, Norris MD.
    Cancer Res; 1994 Oct 01; 54(19):5036-40. PubMed ID: 7923112
    [Abstract] [Full Text] [Related]

  • 2. Expression of multiple drug resistance gene, MDR1, and N-myc oncogene in an Italian population of human neuroblastoma patients.
    Corrias MV, Cornaglia-Ferraris P, Di Martino D, Stenger AM, Lanino E, Boni L, Tonini GP.
    Anticancer Res; 1990 Oct 01; 10(4):897-902. PubMed ID: 1974410
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Activation of N-myc oncogene and associated genes to chemoresistance, prognostic value for neuroblastoma].
    Bénard J, Bourhis J, Riou G.
    Bull Cancer; 1991 Jan 01; 78(1):91-7. PubMed ID: 2021689
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
    Nakagawara A, Kadomatsu K, Sato S, Kohno K, Takano H, Akazawa K, Nose Y, Kuwano M.
    Cancer Res; 1990 May 15; 50(10):3043-7. PubMed ID: 2185879
    [Abstract] [Full Text] [Related]

  • 9. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein.
    Krishnamachary N, Center MS.
    Cancer Res; 1993 Aug 15; 53(16):3658-61. PubMed ID: 8101765
    [Abstract] [Full Text] [Related]

  • 10. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
    Raschella G, Romeo A, Negroni A, Pucci S, Dominici C, Castello MA, Bevilacqua P, Felsani A, Calabretta B.
    Cancer Res; 1994 Apr 15; 54(8):2251-5. PubMed ID: 8174135
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines.
    Zaman GJ, Versantvoort CH, Smit JJ, Eijdems EW, de Haas M, Smith AJ, Broxterman HJ, Mulder NH, de Vries EG, Baas F.
    Cancer Res; 1993 Apr 15; 53(8):1747-50. PubMed ID: 8467491
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
    Fan L, Iyer J, Zhu S, Frick KK, Wada RK, Eskenazi AE, Berg PE, Ikegaki N, Kennett RH, Frantz CN.
    Cancer Res; 2001 Feb 01; 61(3):1073-9. PubMed ID: 11221835
    [Abstract] [Full Text] [Related]

  • 13. The role of c-myc in regulating mdr1 gene expression in tumor cell line KB.
    He Y, Zhang J, Zhang J, Yuan Y.
    Chin Med J (Engl); 2000 Sep 01; 113(9):848-51. PubMed ID: 11776085
    [Abstract] [Full Text] [Related]

  • 14. Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells.
    Grandinetti KB, Spengler BA, Biedler JL, Ross RA.
    Oncogene; 2006 Feb 02; 25(5):706-12. PubMed ID: 16278682
    [Abstract] [Full Text] [Related]

  • 15. Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions.
    Peverali FA, Orioli D, Tonon L, Ciana P, Bunone G, Negri M, Della-Valle G.
    Oncogene; 1996 Jan 18; 12(2):457-62. PubMed ID: 8570225
    [Abstract] [Full Text] [Related]

  • 16. Determination of N-myc gene amplification in neuroblastoma by differential polymerase chain reaction.
    Gilbert J, Norris MD, Haber M, Kavallaris M, Marshall GM, Stewart BW.
    Mol Cell Probes; 1993 Jun 18; 7(3):227-34. PubMed ID: 8366868
    [Abstract] [Full Text] [Related]

  • 17. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
    George RE, Kenyon RM, McGuckin AG, Malcolm AJ, Pearson AD, Lunec J.
    Oncogene; 1996 Apr 04; 12(7):1583-7. PubMed ID: 8622876
    [Abstract] [Full Text] [Related]

  • 18. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
    Cheng NC, Van Roy N, Chan A, Beitsma M, Westerveld A, Speleman F, Versteeg R.
    Oncogene; 1995 Jan 19; 10(2):291-7. PubMed ID: 7838528
    [Abstract] [Full Text] [Related]

  • 19. myc gene amplification and expression in primary human neuroblastoma.
    Slavc I, Ellenbogen R, Jung WH, Vawter GF, Kretschmar C, Grier H, Korf BR.
    Cancer Res; 1990 Mar 01; 50(5):1459-63. PubMed ID: 2302711
    [Abstract] [Full Text] [Related]

  • 20. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
    Godfried MB, Veenstra M, v Sluis P, Boon K, v Asperen R, Hermus MC, v Schaik BD, Voûte TP, Schwab M, Versteeg R, Caron HN.
    Oncogene; 2002 Mar 27; 21(13):2097-101. PubMed ID: 11960382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.